Literature DB >> 28167562

Tenofovir Disoproxil Fumarate Is a New Substrate of ATP-Binding Cassette Subfamily C Member 11.

Wisith Tun-Yhong1, Chatchai Chinpaisal2, Perayot Pamonsinlapatham3, Sindchai Kaewkitichai1.   

Abstract

Tenofovir disoproxil fumarate (TDF), a nucleotide reverse transcriptase inhibitor, after conversion to tenofovir (TFV), is mainly eliminated by glomerular filtration and active tubular secretion. The major adverse effect of tenofovir is nephrotoxicity; however, the exact mechanism remains poorly understood. In this study, the ATP-binding cassette subfamily C member 11 (ABCC11; multidrug resistance protein 8 [MRP8]) transporter, which is abundant in proximal tubular cells, was demonstrated to act as an efflux transporter of tenofovir. Real-time PCR (RT-PCR) and indirect immunofluorescence assays were used to determine MRP8 overexpression in a continuous cell line. Tenofovir accumulations were assessed by cytotoxicity, cellular transport, and vesicular uptake assays. Substrate specificity was confirmed using MK-571, an MRP-specific inhibitor, and methotrexate, which served as a known substrate. Intracellular and intravesicular concentrations of tenofovir were determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS). The 50% cytotoxic concentration (CC50) of TDF in MRP8-overexpressing cells was 4.78 times higher than that of parental cells. Transport assays also showed that the intracellular accumulation of tenofovir in MRP8-overexpressing cells was 55 times lower than that in parental cells and was partly reversed by MK-571. Similarly, an "inside-out" vesicular uptake assay, using Sf9 inverted membrane vesicles to allow measuring of accumulation of the substrates into the vesicles, demonstrated a higher intravesicular concentration of tenofovir in MRP8-overexpressing vesicles than in Sf9 insect control vesicles. These effects were effectively reversed by increasing concentrations of the specific inhibitor MK-571. In conclusion, tenofovir is a new substrate of the MRP8 transporter. An alteration in the activity of this efflux pump may increase the intracellular accumulation of tenofovir in proximal renal tubular cells.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  ABCC11; ATP-binding cassette subfamily C11; MRP8 transporter; methotrexate; nephrotoxicity; tenofovir; tenofovir disoproxil fumarate

Mesh:

Substances:

Year:  2017        PMID: 28167562      PMCID: PMC5365707          DOI: 10.1128/AAC.01725-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  45 in total

1.  Multiple splicing variants of two new human ATP-binding cassette transporters, ABCC11 and ABCC12.

Authors:  H Yabuuchi; H Shimizu; S Takayanagi; T Ishikawa
Journal:  Biochem Biophys Res Commun       Date:  2001-11-09       Impact factor: 3.575

2.  Assessing the (a)symmetry of concentration-effect curves: empirical versus mechanistic models.

Authors:  Jesús Giraldo; Nuria M Vivas; Elisabet Vila; Albert Badia
Journal:  Pharmacol Ther       Date:  2002-07       Impact factor: 12.310

3.  MRP8, a new member of ABC transporter superfamily, identified by EST database mining and gene prediction program, is highly expressed in breast cancer.

Authors:  T K Bera; S Lee; G Salvatore; B Lee; I Pastan
Journal:  Mol Med       Date:  2001-08       Impact factor: 6.354

4.  Genetic variants of ABCC10, a novel tenofovir transporter, are associated with kidney tubular dysfunction.

Authors:  Sudeep P Pushpakom; Neill J Liptrott; Sonia Rodríguez-Nóvoa; Pablo Labarga; Vincent Soriano; Marta Albalater; Elizabeth Hopper-Borge; Stefano Bonora; Giovanni Di Perri; David J Back; Saye Khoo; Munir Pirmohamed; Andrew Owen
Journal:  J Infect Dis       Date:  2011-07-01       Impact factor: 5.226

Review 5.  Chemotherapy-induced resistance by ATP-binding cassette transporter genes.

Authors:  Jean-Pierre Gillet; Thomas Efferth; José Remacle
Journal:  Biochim Biophys Acta       Date:  2007-06-06

6.  Determination of methotrexate and its major metabolite 7-hydroxymethotrexate in mouse plasma and brain tissue by liquid chromatography-tandem mass spectrometry.

Authors:  Ping Guo; Xiaomin Wang; Liansheng Liu; Martin G Belinsky; Gary D Kruh; James M Gallo
Journal:  J Pharm Biomed Anal       Date:  2007-01-12       Impact factor: 3.935

7.  High throughput LC-MS/MS method for simultaneous determination of tenofovir, lamivudine and nevirapine in human plasma.

Authors:  Rajani Kumar Valluru; Phani Bhushana Reddy B; Kalyan Sumanth S; Praveen Kumar V; Naveen Babu Kilaru
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-05-24       Impact factor: 3.205

8.  A new assay based on solid-phase extraction procedure with LC-MS to measure plasmatic concentrations of tenofovir and emtricitabine in HIV infected patients.

Authors:  Antonio D'Avolio; Mauro Sciandra; Marco Siccardi; Lorena Baietto; Daniel Gonzalez de Requena; Stefano Bonora; Giovanni Di Perri
Journal:  J Chromatogr Sci       Date:  2008-07       Impact factor: 1.618

9.  Tenofovir disoproxil fumarate.

Authors:  Joel E Gallant; Stanley Deresinski
Journal:  Clin Infect Dis       Date:  2003-09-12       Impact factor: 9.079

10.  Single nucleotide polymorphisms in ABCC2 associate with tenofovir-induced kidney tubular dysfunction in Japanese patients with HIV-1 infection: a pharmacogenetic study.

Authors:  Takeshi Nishijima; Hirokazu Komatsu; Koichiro Higasa; Misao Takano; Kiyoto Tsuchiya; Tsunefusa Hayashida; Shinichi Oka; Hiroyuki Gatanaga
Journal:  Clin Infect Dis       Date:  2012-09-05       Impact factor: 9.079

View more
  4 in total

1.  Strategies to gain novel Alzheimer's disease diagnostics and therapeutics using modulators of ABCA transporters.

Authors:  Jens Pahnke; Pablo Bascuñana; Mirjam Brackhan; Katja Stefan; Vigneshwaran Namasivayam; Radosveta Koldamova; Jingyun Wu; Luisa Möhle; Sven Marcel Stefan
Journal:  Free Neuropathol       Date:  2021-12-13

Review 2.  Pharmacogenomics of drug transporters for antiretroviral long-acting pre-exposure prophylaxis for HIV.

Authors:  Nomusa M Zondo; Parveen Sobia; Aida Sivro; Sinaye Ngcapu; Veron Ramsuran; Derseree Archary
Journal:  Front Genet       Date:  2022-09-29       Impact factor: 4.772

3.  Binding mode analysis of ABCA7 for the prediction of novel Alzheimer's disease therapeutics.

Authors:  Vigneshwaran Namasivayam; Katja Stefan; Jens Pahnke; Sven Marcel Stefan
Journal:  Comput Struct Biotechnol J       Date:  2021-11-27       Impact factor: 7.271

4.  Methotrexate Decreases Tenofovir Exposure in Antiretroviral-Suppressed Individuals Living With HIV.

Authors:  David Gingrich; Amelia N Deitchman; Amy Kantor; Liusheng Huang; James H Stein; Judith S Currier; Priscilla Y Hsue; Heather J Ribaudo; Francesca T Aweeka
Journal:  J Acquir Immune Defic Syndr       Date:  2020-12-15       Impact factor: 3.771

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.